Inulin and oligofructose: impact on intestinal diseases and disorders.
about
Short chain fatty acids (butyrate) for induction of remission in ulcerative colitisNutritional protective mechanisms against gut inflammationHuman gut microbiota and healthy aging: Recent developments and future prospectiveEffect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii.Antioxidant activity of inulin and its role in the prevention of human colonic muscle cell impairment induced by lipopolysaccharide mucosal exposure.Nutriose, a prebiotic low-digestible carbohydrate, stimulates gut mucosal immunity and prevents TNBS-induced colitis in piglets.In vitro and in vivo survival and transit tolerance of potentially probiotic strains carried by artichokes in the gastrointestinal tractA novel strategy in production of oligosaccharides in digestive tract: prevention of postprandial hyperglycemia and hyperinsulinemiaRole of nutraceuticals in human health.The pig as an experimental model for elucidating the mechanisms governing dietary influence on mineral absorption.Probiotics in pregnancy and maternal outcomes: a systematic review.Optimization of Sugar Replacement with Date Syrup in Prebiotic Chocolate Milk Using Response Surface Methodology.Functional metagenomic investigations of the human intestinal microbiota.Cross-feeding between Bifidobacterium longum BB536 and acetate-converting, butyrate-producing colon bacteria during growth on oligofructose.Gut microbial translocation in critically ill children and effects of supplementation with pre- and pro biotics.Effects of probiotic, prebiotic, and synbiotic with and without feed restriction on performance, hematological indices and carcass characteristics of broiler chickens.Gut microbiota and pregnancy, a matter of inner life.Effects of different oligosaccharides at various dosages on the composition of gut microbiota and short-chain fatty acids in mice with constipation.Effect of Honey on Diarrhea and Fecal Microbiotain in Critically Ill Tube-Fed Patients: A Single Center Randomized Controlled Study.New Biodegradable Hydrogels Based on Inulin and α,β-Polyaspartylhydrazide Designed for Colonic Drug Delivery: In Vitro Release of Glutathione and Oxytocin
P2860
Q24234780-94C4D841-ABCF-435A-AB36-AE5D088D72EEQ27028202-D5F415C6-022A-489D-A2BD-63D2E2322222Q28586306-AD0392A1-CEF4-4923-86B1-53F6774CB85CQ33347944-8B3393F6-BE91-47BA-BD8F-EF163F6CC70FQ33623914-5B177364-4B73-4730-8A25-1BD2872A2608Q34020518-EF182A3A-22B7-4C59-A426-81E1A623C019Q34570646-602B2C27-30E7-4938-8130-EB0D9193EF29Q36459997-31E6F14F-448C-4F08-B942-D50C4A0607C7Q36550274-DAA14A98-8D55-48A8-96B1-14551F8074A8Q37137193-7C12AEFB-CF75-4A27-A657-111AC7296E16Q38064511-D56B773F-7334-4741-9F81-EEAF6B177BCCQ38659080-FBE3720B-B745-4D48-B28E-DB7D6167B6ACQ38729839-35C31BC8-6899-4399-B7CD-773ADE22D177Q40910755-6A92C4F6-7D40-492D-8BD9-6D5CE8EFDFE7Q42014198-22C3A724-2022-4320-9229-6418EF465642Q42147037-F0D5E122-D852-4035-A646-3A323573E035Q46200024-5889CFF5-D633-41CF-939E-57BEBEA9A5F9Q46371345-20066E4B-7E64-4786-8B14-A38C090297B2Q55093174-234CC32E-9888-4B4B-9A88-A8A0C981E8F9Q57380450-A4706A3B-D2CA-48C1-85E5-658DA9CA4E62
P2860
Inulin and oligofructose: impact on intestinal diseases and disorders.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Inulin and oligofructose: impact on intestinal diseases and disorders.
@ast
Inulin and oligofructose: impact on intestinal diseases and disorders.
@en
Inulin and oligofructose: impact on intestinal diseases and disorders.
@nl
type
label
Inulin and oligofructose: impact on intestinal diseases and disorders.
@ast
Inulin and oligofructose: impact on intestinal diseases and disorders.
@en
Inulin and oligofructose: impact on intestinal diseases and disorders.
@nl
prefLabel
Inulin and oligofructose: impact on intestinal diseases and disorders.
@ast
Inulin and oligofructose: impact on intestinal diseases and disorders.
@en
Inulin and oligofructose: impact on intestinal diseases and disorders.
@nl
P2860
P356
P1476
Inulin and oligofructose: impact on intestinal diseases and disorders.
@en
P2860
P356
10.1079/BJN20041345
P478
93 Suppl 1
P577
2005-04-01T00:00:00Z